These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

892 related items for PubMed ID: 18222347

  • 1. The role of secretory IgA and complement in IgA nephropathy.
    Oortwijn BD, Eijgenraam JW, Rastaldi MP, Roos A, Daha MR, van Kooten C.
    Semin Nephrol; 2008 Jan; 28(1):58-65. PubMed ID: 18222347
    [Abstract] [Full Text] [Related]

  • 2. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
    Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C.
    J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
    [Abstract] [Full Text] [Related]

  • 3. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
    Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha MR.
    J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
    [Abstract] [Full Text] [Related]

  • 4. Demonstration of secretory IgA in kidneys of patients with IgA nephropathy.
    Oortwijn BD, Rastaldi MP, Roos A, Mattinzoli D, Daha MR, van Kooten C.
    Nephrol Dial Transplant; 2007 Nov; 22(11):3191-5. PubMed ID: 17545679
    [Abstract] [Full Text] [Related]

  • 5. Pathogenesis of IgA nephropathy.
    Feehally J, Allen AC.
    Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
    [Abstract] [Full Text] [Related]

  • 6. Role of complement in IgA nephropathy.
    Daha MR, van Kooten C.
    J Nephrol; 2016 Feb; 29(1):1-4. PubMed ID: 26567162
    [Abstract] [Full Text] [Related]

  • 7. Immunofluorescent studies on S-protein in glomeruli from patients with IgA nephropathy.
    Tomino Y, Yagame M, Eguchi K, Nomoto Y, Sakai H.
    Am J Pathol; 1987 Nov; 129(2):402-6. PubMed ID: 3314533
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].
    Segarra A.
    Nefrologia; 2010 Nov; 30(5):501-7. PubMed ID: 20882091
    [Abstract] [Full Text] [Related]

  • 10. Participation of complement components in glomerular deposition in IgA nephropathy.
    Suzuki S.
    Nihon Jinzo Gakkai Shi; 1989 Oct; 31(10):1029-37. PubMed ID: 2615014
    [Abstract] [Full Text] [Related]

  • 11. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 12. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.
    Hashimoto A, Suzuki Y, Suzuki H, Ohsawa I, Brown R, Hall S, Tanaka Y, Novak J, Ohi H, Tomino Y.
    Am J Pathol; 2012 Oct; 181(4):1338-47. PubMed ID: 22871574
    [Abstract] [Full Text] [Related]

  • 13. The role of complement in IgA nephropathy.
    Tortajada A, Gutierrez E, Pickering MC, Praga Terente M, Medjeral-Thomas N.
    Mol Immunol; 2019 Oct; 114():123-132. PubMed ID: 31351413
    [Abstract] [Full Text] [Related]

  • 14. [Haemophilus parainfluenzae antigens in IgA nephropathy].
    Suzuki S, Kimura H, Gejyo F.
    Rinsho Byori; 1998 Jan; 46(1):17-25. PubMed ID: 9492534
    [Abstract] [Full Text] [Related]

  • 15. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A, Sheu LF, Ding SL, Lee WH.
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [Abstract] [Full Text] [Related]

  • 16. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice.
    Zheng F, Kundu GC, Zhang Z, Ward J, DeMayo F, Mukherjee AB.
    Nat Med; 1999 Sep; 5(9):1018-25. PubMed ID: 10470078
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of the Lectin Pathway of the Complement System as a Novel Approach in the Management of IgA Vasculitis-Associated Nephritis.
    Selvaskandan H, Kay Cheung C, Dormer J, Wimbury D, Martinez M, Xu G, Barratt J.
    Nephron; 2020 Sep; 144(9):453-458. PubMed ID: 32721954
    [Abstract] [Full Text] [Related]

  • 18. Complement Activation Is Associated With Crescents in IgA Nephropathy.
    Wang Z, Xie X, Li J, Zhang X, He J, Wang M, Lv J, Zhang H.
    Front Immunol; 2021 Sep; 12():676919. PubMed ID: 34594322
    [Abstract] [Full Text] [Related]

  • 19. Secondary IgA nephropathy.
    Pouria S, Barratt J.
    Semin Nephrol; 2008 Jan; 28(1):27-37. PubMed ID: 18222344
    [Abstract] [Full Text] [Related]

  • 20. Complement system is overactivated in patients with IgA nephropathy after COVID-19.
    Guo WY, Wang GQ, Kong LQ, Sun LJ, Xu XY, Cheng WR, Dong HR, Cheng H.
    Clin Immunol; 2024 Jun; 263():110232. PubMed ID: 38701960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.